Prudential Financial Inc Corcept Therapeutics Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 98,142 shares of CORT stock, worth $5.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

98,142

Previous 97,508 0.65%

Holding current value

$5.38 Million

Previous $3.17 Million 43.31%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$29.51 - $46.26 $18,709 - $29,328	634 Added 0.65%	98,142 $4.54 Million
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $87,640 - $136,058	-3,946 Reduced 3.89%	97,508 $3.17 Million
Q1 2024 May 14, 2024	SELL	$21.1 - $27.46 $34,667 - $45,116	-1,643 Reduced 1.59%	101,454 $2.56 Million
Q4 2023 Feb 13, 2024	SELL	$24.82 - $32.88 $55,125 - $73,026	-2,221 Reduced 2.11%	103,097 $3.35 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $130,875 - $201,346	-5,957 Reduced 5.35%	105,318 $2.87 Million
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $391,730 - $459,515	18,271 Added 19.65%	111,275 $2.48 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $61,824 - $78,793	-3,220 Reduced 3.35%	93,004 $2.01 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $5,785 - $8,688	-290 Reduced 0.3%	96,224 $0
Q3 2022 Nov 04, 2022	SELL	$24.7 - $29.12 $29,022 - $34,216	-1,175 Reduced 1.2%	96,514 $2.48 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $29,547 - $43,136	-1,705 Reduced 1.72%	97,689 $2.32 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $41,341 - $63,050	-2,501 Reduced 2.45%	99,394 $2.24 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $181,875 - $248,244	-10,636 Reduced 9.45%	101,895 $2.02 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $26,469 - $30,302	-1,345 Reduced 1.18%	112,531 $2.22 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $155,166 - $189,821	-7,770 Reduced 6.39%	113,876 $2.51 Million
Q1 2021 May 12, 2021	SELL	$23.49 - $30.56 $70,516 - $91,741	-3,002 Reduced 2.41%	121,646 $2.89 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $946,660 - $1.54 Million	-56,416 Reduced 31.16%	124,648 $3.26 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $237,986 - $381,618	19,100 Added 11.79%	181,064 $3.15 Million
Q2 2020 Aug 12, 2020	SELL	$11.0 - $18.26 $447,216 - $742,378	-40,656 Reduced 20.07%	161,964 $2.72 Million
Q1 2020 May 12, 2020	SELL	$10.11 - $14.04 $71,558 - $99,375	-7,078 Reduced 3.38%	202,620 $2.41 Million
Q4 2019 Feb 11, 2020	BUY	$12.06 - $16.96 $199,195 - $280,128	16,517 Added 8.55%	209,698 $2.54 Million
Q3 2019 Nov 13, 2019	BUY	$10.41 - $14.66 $25,535 - $35,960	2,453 Added 1.29%	193,181 $2.73 Million
Q2 2019 Aug 08, 2019	BUY	$9.78 - $12.76 $143,345 - $187,023	14,657 Added 8.32%	190,728 $0
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $30,561 - $47,868	3,047 Added 1.76%	176,071 $0
Q4 2018 Feb 07, 2019	SELL	$11.29 - $17.19 $22,568 - $34,362	-1,999 Reduced 1.14%	173,024 $2.31 Million
Q3 2018 Nov 07, 2018	SELL	$12.27 - $15.65 $149,571 - $190,773	-12,190 Reduced 6.51%	175,023 $0
Q2 2018 Aug 13, 2018	SELL	$15.3 - $19.69 $3.71 Million - $4.78 Million	-242,660 Reduced 56.45%	187,213 $0
Q1 2018 May 04, 2018	SELL	$14.59 - $25.5 $18.5 Million - $32.3 Million	-1,265,290 Reduced 74.64%	429,873 $0
Q4 2017 Feb 13, 2018	BUY	$15.77 - $20.72 $9.35 Million - $12.3 Million	592,680 Added 53.76%	1,695,163 $30.6 Million
Q3 2017 Nov 02, 2017	BUY	$12.3 - $19.3 $13.6 Million - $21.3 Million	1,102,483	1,102,483 $21.3 Million

Others Institutions Holding CORT

# of Institutions

339

Shares Held

86.5M

Call Options Held

1.27M

Put Options Held

454K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Corcept Therapeutics Inc Transaction History